Literature DB >> 23371825

The impact of a ketogenic diet and liver dysfunction on serum very long-chain fatty acids levels.

T J Stradomska1, M Bachański, J Pawłowska, M Syczewska, A Stolarczyk, A Tylki-Szymańska.   

Abstract

Peroxisomes play an essential role in mammalian cellular metabolism, particularly in oxidation fatty acid pathways. Serum very long-chain fatty acids (VLCFA), the main biochemical diagnostic parameters for peroxisomal disorders, were examined in 25 neurological patients with epilepsy on a ketogenic diet and 27 patients with liver dysfunction. The data show that patients on a ketogenic diet have increased levels of C22:0 and C24:0, but not C26:0, and normal C24:0/C22:0 and C26:0/C22:0. Patients with liver insufficiency showed a slightly elevated level of C26:0, a normal level of C24:0 and a decreased level of C22:0; thus in 21/27 the ratio of C24:0/C22:0 was increased and 15/27 the ratio of C26:0/C22:0 was increased.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23371825     DOI: 10.1007/s11745-013-3761-y

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  21 in total

Review 1.  The peroxisomal protein import machinery.

Authors:  Harald W Platta; Ralf Erdmann
Journal:  FEBS Lett       Date:  2007-04-09       Impact factor: 4.124

Review 2.  Peroxisomal ABC transporters: structure, function and role in disease.

Authors:  Masashi Morita; Tsuneo Imanaka
Journal:  Biochim Biophys Acta       Date:  2012-02-17

3.  Decreasing serum VLCFA levels in ageing X-ALD female carriers.

Authors:  T J Stradomska; A Tylki-Szymańska
Journal:  J Inherit Metab Dis       Date:  2001-12       Impact factor: 4.982

4.  Very long-chain fatty acids in Rett syndrome.

Authors:  T J Stradomska; A Tylki-Szymańska; Z Bentkowski
Journal:  Eur J Pediatr       Date:  1999-03       Impact factor: 3.183

5.  Increased very long chain fatty acids in patients on a ketogenic diet: a cause of diagnostic confusion.

Authors:  C Theda; R C Woody; S Naidu; A B Moser; H W Moser
Journal:  J Pediatr       Date:  1993-05       Impact factor: 4.406

6.  Nervonic acid biosynthesis by erucyl-CoA elongation in normal and quaking mouse brain microsomes. Elongation of other unsaturated fatty acyl-CoAs (mono and poly-unsaturated).

Authors:  J M Bourre; O Daudu; N Baumann
Journal:  Biochim Biophys Acta       Date:  1976-01-22

7.  Differential substrate specificities of human ABCD1 and ABCD2 in peroxisomal fatty acid β-oxidation.

Authors:  Carlo W T van Roermund; Wouter F Visser; Lodewijk Ijlst; Hans R Waterham; Ronald J A Wanders
Journal:  Biochim Biophys Acta       Date:  2010-12-08

Review 8.  Peroxisomal disorders I: biochemistry and genetics of peroxisome biogenesis disorders.

Authors:  R J A Wanders; H R Waterham
Journal:  Clin Genet       Date:  2005-02       Impact factor: 4.438

9.  Diagnosis of X-linked adrenoleukodystrophy in blood leukocytes.

Authors:  Ursula Unterberger; Günther Regelsberger; Regina Sundt; Hanno Bernheimer; Till Voigtländer
Journal:  Clin Biochem       Date:  2007-05-03       Impact factor: 3.281

10.  PeroxisomeDB: a database for the peroxisomal proteome, functional genomics and disease.

Authors:  Agatha Schlüter; Stéphane Fourcade; Enric Domènech-Estévez; Toni Gabaldón; Jaime Huerta-Cepas; Guillaume Berthommier; Raymond Ripp; Ronald J A Wanders; Olivier Poch; Aurora Pujol
Journal:  Nucleic Acids Res       Date:  2006-11-28       Impact factor: 16.971

View more
  9 in total

Review 1.  Peroxisome biogenesis disorders in the Zellweger spectrum: An overview of current diagnosis, clinical manifestations, and treatment guidelines.

Authors:  Nancy E Braverman; Gerald V Raymond; William B Rizzo; Ann B Moser; Mark E Wilkinson; Edwin M Stone; Steven J Steinberg; Michael F Wangler; Eric T Rush; Joseph G Hacia; Mousumi Bose
Journal:  Mol Genet Metab       Date:  2015-12-23       Impact factor: 4.797

Review 2.  The Changing Face of Adrenoleukodystrophy.

Authors:  Jia Zhu; Florian Eichler; Alessandra Biffi; Christine N Duncan; David A Williams; Joseph A Majzoub
Journal:  Endocr Rev       Date:  2020-08-01       Impact factor: 19.871

3.  Zellweger Syndrome Disorders: From Severe Neonatal Disease to Atypical Adult Presentation.

Authors:  David Cheillan
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

4.  Mild Zellweger syndrome due to a novel PEX6 mutation: correlation between clinical phenotype and in silico prediction of variant pathogenicity.

Authors:  Małgorzata Rydzanicz; Teresa Joanna Stradomska; Elżbieta Jurkiewicz; Ewa Jamroz; Piotr Gasperowicz; Grażyna Kostrzewa; Rafał Płoski; Anna Tylki-Szymańska
Journal:  J Appl Genet       Date:  2017-10-18       Impact factor: 3.240

5.  False-positive very long-chain fatty acids in a case of autoimmune adrenal insufficiency.

Authors:  Jia Zhu; David T Breault
Journal:  J Pediatr Endocrinol Metab       Date:  2020-12-14       Impact factor: 1.520

6.  The Impact of Kidney Transplantation on the Serum Fatty Acid Profile in Patients with End-Stage Kidney Disease.

Authors:  Maciej Śledziński; Aleksandra Hliwa; Justyna Gołębiewska; Adriana Mika
Journal:  Nutrients       Date:  2022-02-12       Impact factor: 5.717

7.  Changes in the Serum Fatty Acid Profile After Anhepatic Phase of Orthotopic Liver Transplantation Procedure.

Authors:  Aleksandra Hliwa; Adriana Mika; Maciej Sledzinski; Dariusz Laski; Bruno Ramos-Molina; Tomasz Sledzinski
Journal:  Front Physiol       Date:  2022-03-29       Impact factor: 4.566

Review 8.  ABCD1 Gene Mutations: Mechanisms and Management of Adrenomyeloneuropathy.

Authors:  Alyssa M Volmrich; Lauren M Cuénant; Irman Forghani; Sharon L Hsieh; Lauren T Shapiro
Journal:  Appl Clin Genet       Date:  2022-08-12

9.  Laboratory diagnosis of disorders of peroxisomal biogenesis and function: a technical standard of the American College of Medical Genetics and Genomics (ACMG).

Authors:  Irene De Biase; Silvia Tortorelli; Lisa Kratz; Steven J Steinberg; Kristina Cusmano-Ozog; Nancy Braverman
Journal:  Genet Med       Date:  2019-12-11       Impact factor: 8.822

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.